vaccines. so studies like yours are really giving us the information we need. what do you need to hear specifically about who and what -- who specifically is going to get this third shot? what do you need to hear from the fda? >> yeah, thanks for chatting with me about this today. so the prospect of booster dose authorization for people who are immunocompromised and did not have a good response to only a two-dose vaccine series is obviously very exciting to millions of people living in the united states who are immuno suppressed important some reason. of course, it is particularly exciting for transplant patients who have known since march that we already have growing evidence that the protection offered by a two-dose vaccine series is limited in people who are immuno